Welcome to The Breast Cancer Network News

The BCN News provides its 20,000 readers with breaking news on breast cancer treatment and research daily. Along with thousands of breast cancer patients and survivors, The BCN News is read in nearly every major cancer and health organization, all the major breast cancer organizations, and major research laboratories and universities around the world.

For a free trial subscription to The BCN News, sign up here, or use the following Constant Contact subscribe option:

Join Our Mailing List
Email:


Today's News Sponsors

Triple Breast Cancer Foundation Night 4 Pink Young Women and Breast Cancer: The Empowerment Series Save the Girls Tour of Long Beach Island
The Triple Negative Breast Cancer Foundation
Our Inspiration

Understanding Triple Negative Breast Cancer These subtypes of breast cancer are generally diagnosed based upon the presence, or lack of, three "receptors" known to fuel most breast cancers: estrogen receptors, progesterone receptors and human epidermal growth factor receptor 2 (HER2). The most successful treatments for breast cancer target these receptors.

Unfortunately, none of these receptors are found in women with triple negative breast cancer. In other words, a triple negative breast cancer diagnosis means that the offending tumor is estrogen receptor-negative, progesterone receptor-negative and HER2-negative, thus giving rise to the name "triple negative breast cancer." On a positive note, this type of breast cancer is typically responsive to chemotherapy. However, triple negative tumors generally do not respond to receptor targeted treatments, and they can be particularly aggressive, and more likely to recur.

The Triple Negative Breast Cancer Foundation is devoted to finding targeted treatment for triple negative breast cancer. With your help, we will find a cure.

Download a PDF of the Guide to Understanding Triple Negative Breast Cancer, developed in collaboration with Living Beyond Breast Cancer.

For more information on Triple Negative Breast Cancer, our Foundation, or how you can help find a cure, visit: TNBCFoundation.org



BCN News Articles for: September 23, 2014

  • Stanford researchers create 'evolved' protein that may stop cancer from spreading
  • An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis
  • More treatment options for women with hormone receptor-positive breast cancer: Guideline update, studies lead to advances in care
  • The Role of the Family Environment and Computer-Mediated Social Support on Breast Cancer Patients' Coping Strategies
  • Breast reconstruction after mastectomy among Department of Defense beneficiaries by race
  • Tumor Biology Correlates With Rates of Breast-Conserving Surgery and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: Findings From the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial
  • Comorbidity, Chemotherapy Toxicity, and Outcomes Among Older Women Receiving Adjuvant Chemotherapy for Breast Cancer on a Clinical Trial: CALGB 49907 and CALGB 361004 (Alliance)
  • Meeting the Information Needs of Lower Income Cancer Survivors: Results of a Randomized Control Trial Evaluating the American Cancer Society's "I Can Cope"
  • E-cigarettes unhelpful in smoking cessation among cancer patients
  • Electronic cigarette use among patients with cancer: Characteristics of electronic cigarette users and their smoking cessation outcomes
  • New non-invasive technique could revolutionize the imaging of metastatic cancer
  • AEG-1 promoter-mediated imaging of prostate cancer


Current BCN News subscribers can access the full site, including all of today's articles as well as three years of breast cancer news, by entering their email address below:

Email:
Not a subscriber yet? Sign up now for a free 2-week trial subscription, which includes full site access.

The BCN News: The Cancer News You Need To Know